Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team ...
A study has identified a key disruption in cholesterol transport to the brain in patients with Alzheimer's disease. The findings suggest that the lipoproteins in the cerebrospinal fluid of patients ...
This study illustrates the spatiotemporal dynamics of neuron subtype changes within the entorhinal cortex–hippocampal circuit during Alzheimer’s disease progression. EC-stellate neurons progressively ...
Brain cells are constantly swallowing material from the fluid that surrounds them—signaling molecules, nutrients, even pieces of their own surfaces—in a process known as endocytosis that is essential ...
A new study has pinpointed how the APOE4 gene variant sabotages the brain’s energy balance, blocking neurons from burning fat for fuel when glucose runs low, a discovery that could reveal new ways to ...
CAMBRIDGE, Mass., Sept. 10, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe ...
News-Medical.Net on MSN
Causal gene mapping identifies key drivers of Alzheimer's disease progression
Researchers led by Min Zhang and Dabao Zhang of the University of California, Irvine's Joe C. Wen School of Population & Public Health have created the most detailed maps to date showing how genes ...
A new study from scientists at the Buck Institute for Research on Aging has revealed a surprising player in the battle against Alzheimer's disease and other forms of dementia: brain sugar metabolism.
Scientists do not fully understand what causes the chronic neurodegenerative disease Alzheimer's, but they are examining a combination of genetic, health and lifestyle factors. On social media, false ...
In an exciting breakthrough, researchers have identified cancer drugs that might reverse the effects of Alzheimer's disease in the brain. By analyzing gene expression in brain cells, they discovered ...
A study led by the Sant Pau Research Institute (IR Sant Pau), the Clinical Biochemistry Service at Hospital de Sant Pau, and the Spanish Biomedical Research Network in Diabetes and Associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results